- Home
- EDTK vs ASBP Comparison
EDTK vs ASBP Comparison
Compare EDTK & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDTK
- ASBP
- Stock Information
- Founded
- EDTK 2013
- ASBP 2021
- Country
- EDTK China
- ASBP United States
- Employees
- EDTK N/A
- ASBP N/A
- Industry
- EDTK Other Consumer Services
- ASBP Biotechnology: Pharmaceutical Preparations
- Sector
- EDTK Real Estate
- ASBP Health Care
- Exchange
- EDTK Nasdaq
- ASBP Nasdaq
- Market Cap
- EDTK 17.7M
- ASBP 18.7M
- IPO Year
- EDTK 2020
- ASBP N/A
- Fundamental
- Price
- EDTK $1.03
- ASBP $0.34
- Analyst Decision
- EDTK
- ASBP
- Analyst Count
- EDTK 0
- ASBP 0
- Target Price
- EDTK N/A
- ASBP N/A
- AVG Volume (30 Days)
- EDTK 13.0K
- ASBP 40.6M
- Earning Date
- EDTK 08-08-2025
- ASBP 11-24-2025
- Dividend Yield
- EDTK N/A
- ASBP N/A
- EPS Growth
- EDTK N/A
- ASBP N/A
- EPS
- EDTK N/A
- ASBP N/A
- Revenue
- EDTK $893,690.00
- ASBP N/A
- Revenue This Year
- EDTK N/A
- ASBP N/A
- Revenue Next Year
- EDTK N/A
- ASBP N/A
- P/E Ratio
- EDTK N/A
- ASBP N/A
- Revenue Growth
- EDTK N/A
- ASBP N/A
- 52 Week Low
- EDTK $0.80
- ASBP $0.20
- 52 Week High
- EDTK $1.20
- ASBP $15.80
- Technical
- Relative Strength Index (RSI)
- EDTK 44.53
- ASBP 45.57
- Support Level
- EDTK $1.03
- ASBP $0.32
- Resistance Level
- EDTK $1.11
- ASBP $0.36
- Average True Range (ATR)
- EDTK 0.04
- ASBP 0.06
- MACD
- EDTK -0.01
- ASBP 0.00
- Stochastic Oscillator
- EDTK 0.00
- ASBP 53.54
About EDTK Skillful Craftsman Education Technology Limited
Skillful Craftsman Education Technology Ltd provides online education and technology services in China. The services comprises of two aspects - Online vocational training and Virtual simulation experimental training. It covers a wide range of subjects, including mechanics, electronics, auto repair and construction. Majority of its revenues are generated from the People's Republic of China.
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.